Seguridad de las vacunas contra la Covid-19
Dados Bibliográficos
| ID | 15534943 |
|---|---|
| Autores | Nataniel Aldo Chaparro Mérida (Fundación PROINPA, autor correspondente), Dayany Moreno Samper (0000-0003-2513-6265, Hospital Oncológico Docente "Conrado Benítez García"), Alex Omar Franco Lacato (0000-0001-6653-4142, Universidad Privada de Santa Cruz de la Sierra) |
| Ano | 2021 |
| Volume | 38 |
| Fascículo | 4 |
| Páginas | 634-42 |
| Data de publicação | 2021-12-22 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Revista Peruana de Medicina Experimental y Salud Pública (JOURNAL) |
| Identificadores do periódico | ISSN: 1726-4634 • E-ISSN: 1726-4642 |
| Editora | National Institute of Health of Peru (PUBLISHER • PE) |
| DOI | 10.17843/rpmesp.2021.384.9308 |
| PMID | 35385018 |
| OpenAlex | W4206235672 |
| Idioma | ES |
| Citações recebidas | 2 |
| Referências citadas | 6 |
The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic. Adverse events following immunization are unwanted responses or unintended events that must be carefully monitored, as all vaccines, including those developed against SARS-CoV-2, are required to meet safety criteria for administration in humans. Information was collected from the PubMed/Medline database during the months of August 2020 to November 2021. Most adverse events reported in clinical trials were mild or moderate; however, thrombotic events associated with some viral vector-based vaccines against COVID-19 were identified in follow-up studies, although completion of the various ongoing studies and post-marketing surveillance is required to determine all potential adverse events, as well as those of special interest
2019-20 coronavirus outbreak · Adverse effect · Coronavirus disease 2019 (COVID-19 · Disease · Humanities · Infectious disease (medical specialty · Outbreak · Pandemic · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · COVID-19 Clinical Research Studies · Heparin-Induced Thrombocytopenia and Thrombosis · Medicine · Philosophy · SARS-CoV-2 and COVID-19 Research · Internal Medicine · Virology
| Obras citantes distintas | 2 |
|---|---|
| Citações por ano | 0,67 |
| Intervalo de citações | 2023 - 2024 (2) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 2 |